β-adrenoceptor subtypes and their desensitization mechanisms

Journal of Autonomic Pharmacology

Volumn 17, Issue 6, 1997, Pages 331-343

  Summers, R J ^a,b   Kompa, A ^a,b   Roberts, S J ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; RECEPTOR SUBTYPE;

HORMONAL REGULATION; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031447590     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1997.00055.x     Document Type: Review

References (113)

1. ARBEENY, C.M., MEYERS, D.S. HILLYER, D.E. & BERGQUIST, K.E. (1995). Metabolic alterations associated with the antidiabetic effect of beta 3-adrenergic receptor agonists in obese mice. Am. J. Physiol., 268, E678-684.
2. ARCH, J.R. AINSWORTH, A.T., CAWTHORNE, M.A. PIERCY, V., SENNITT, M v. & THODY, V.E. (1984). Atypical beta-adrenoceptor on brown adipocytes a target for anti-obesity drugs. Nature, 309, 163-165.
3. ARCH, J.R & KAUMANN, A.J. (1993). Beta 3 and atypical beta-adrenoceptors. Med. Res. Rev., 13, 663-729.
4. ARNOLD, I.R., MISTRY, R. & BARNETT, D.B. (1993). Subtype selective regulation of coupling of rat cardiac beta adrenoceptors to adenylate cyclase. Eur. J. Pharmacol., 245, 285-289.
5. ASANO. T., KATADA, T., GILMAN, A. G. & ROSS, E.M. (1984). Activation of the inhibitory GTP-binding protein of adenylate cyclase, Gi, by beta-adrenergic receptors in reconstituted phospholipid vesicles. J. Biol. Chem., 259, 9351-9354.
6. BALTENSPERGER, K., KAROOR, V., PAUL, H., RUOHO, A., CZECH, M.P. & MALBON, C. C. (1996). The beta-adrenergic receptor is a substrate for the insulin receptor tyrosine kinase. J. Biol. Chem., 271, 1061-1064.
7. BARNES, P.J. (1995). Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med., 152, 838-860.
8. BENGTSSON, T., REDEGREN K., STROSBERG, A.D., NEDERGAARD, J. & CANNON, B. (1996). Down-regulation of beta3 adrenoreceptor gene expression in brown fat cells is transient and recovery is dependent upon a short-lived protein factor. J. Biol. Chem., 271, 33366-33375.
9. BENOVIC, J.L., MAYOR, F.J., STANISZEWSKI, C., LEFKOWITZ, R.J. & CARON, M.G. (1987). Purification and characterization of the beta-adrenergic receptor kinase. J. Biol. Chem., 262, 9026-9032.
10. BIRNBAUMER, L. (1992). Receptor-to-effector signaling through G proteins: roles for βγ dimers as well as α subunits. Cell, 71, 1069-1072.
11. BLIN, N., CAMON, L., MAIGRET, B. & STROSBERG, A.D. (1993). Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor. Mol. Pharmacol., 44, 1094-1104.
12. BLOOM, J.D., DUTIA, M.D., JOHNSON. B.D., WISSNER, A., BURNS, M.G., LARGIS, E.E., DOLAN, J.A. & CLAUS,T.H. (1992). Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino]propyl]-1,3-benzodioxole- 2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent. J. Med. Chem., 35, 3081-3084.
13. BOUVIER, M., HAUSDORFF, W.P., DE BLASI, A., ODOWD, B.F., KOBILKA, B.K., CARON, M.G. & LEFKOWITZ, R.J. (1988). Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitisation. Nature, 333, 370-373.
14. BRAMICH, N.J., BROCK, J.A., EDWARDS, F. R. & HIRST, G.D. (1993). Responses to sympathetic nerve stimulation of the sinus venosus of the toad. J. Physiol., Lond., 461, 403-430.
15. BRAY, P., CARTER, A., SIMONS, C., GUO. V., PUCKETT, C., KAMHOLZ, J., SPIEGEL, A. & NIRENBERG, M. (1986). Human cDNA clones for four species of G alpha s signal transduction protein. Proc. Natl. Sci. USA, 83, 8893-8897.
16. BRENT, G.A., MOORE, D.D. & LARSEN, P.R. (1991). Thyroid hormone regulation of gene expression. Annu. Rev. Physiol., 53, 17-35.
17. BROWN, A.M. (1990). Regulation of heartbeat by G protein-coupled ion channels. Am. J. Physiol., 259, H1621-H1628.
18. CAMPS, M., CAROZZI, A., SCHNABEL, P., SCHEER, A., PARKER, P.J. & GIERSCHIK, P. (1992). Isozyme-selective stimulation of phospholipase C-beta 2 by G protein beta gamma-subunits. Nature, 360, 684-686.
19. CARPENE, C., GALITZKY, J., COLLON, P., ESCLAPEZ, F., DAUZATS, M., & LAFONTAN, M. (1993). Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion. J. Pharmacol. Exp. Ther., 265, 237-247.
20. CERVANTES-OLIVIER, P., DELAVIER-KLUTCHKO, C., DURIEU TRAUTMANN, O., KAVERI, S., DESMANDRIL, M. & STROSBERG, A.D (1988). The beta 2-adrenergic receptors of human epidermoid carcinoma cells bear two different types of oligosaccharides which influence expression on the cell surface. Biochem, J., 250, 133-143.
21. CHAUDRY, A., MACKENZIE, R.G,. GEORGIC, L.M. & GRANNEMAN, J. G. (1994) Differential interaction of beta(l)- and beta(3)-adrenergic receptors with G(i) in rat adipocytes. Cellular Signalling, 6, 457-465.
22. CHEN, X.H., HARDEN, T. K. & NICHOLAS, R. A. (1994). Molecular cloning and characterization of a novel beta-adrenergic receptor. J. Biol. Chem., 269, 24810-24819.
23. CHOATE, J.K., EDWARDS, F.R., HIRST, G.D. & O'SHEA, J.E. (1993a). Effects of sympathetic nerve stimulation on the sino-atrial node of the guinea-pig. J. Physiol., Lond., 471, 707-727.
24. CHOATE, J.K., KLEMM, M. & HIRST, G.D. (1993b). Sympathetic and parasympathetic neuromuscular junctions in the guineapig sino-atrial node. J. Auton. Nerv. Syst., 44, 1-15.
25. CHUNG, F.Z., LENTES, K.U., GOCAYNF, J., FITZGERALD, M., ROBINSON, D., KERLAVAGE, A.R., FRASER, C M. & VENTFR, J.C. (1987). Cloning and sequence analysis of the human brain beta-adrenergic receptor. Evolutionary relationship to rodent and avian beta-receptors and porcine muscarinic receptors. Febs Lett., 211, 200-206.
26. GOLLINS, S., DANIEL, K.W., ROHLFS, F.M., RAMKUMAR, V., TAYLOR. LL. & GETTYS, T.W. (1994). Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol. Endocrnol., 8, 518-527.
27. COOK, S.J., SMALL, R.C., BERRY, J.L., CHIU, P., DOWNING, S J. & FOSTER, R. W. (1993). Beta-adrenoceptor subtypes and the opening of plasmalemmal K+ channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue. Br. J. Pharmacol., 109, 1140-1148.
28. DIXON, R.A., KOBILKA, B.K., STRADER, D.J. ET AL., (1986). Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature, 321, 75-79.
29. DIXON, R.A., SIGAL, I.S., CANDELORE, M.R., REGISTER, R.B., SCATTERGOOD, W., HANDS, E. & STRADER, C.D. (1987). Structural features required for ligand binding to the β-adrenergic receptor. Embo J., 6, 3269-3275.
30. DIXON, R.A., SIGAL, I.S. & STRADER, C.D. (1988). Structure-function analysis of the beta-adrenergic receptor. Cold Spring Harb. Symp. Quant. Biol., 1, 487-497.
31. DOHLMAN, H.G., BOUVIER, M., BENOVIC, J.L., CARON, M.G. & LEFKOWITZ, R.J. (1987). The multiple membrane spanning topography of the beta 2-adrenergic receptor. Localization of the sites of binding, glycosylation, and regulatory phosphorylation by limited proteolysis. J. Biol. Chem., 262, 14282-14288.
32. DOHLMAN, H.G., CARON, M.G., DEBLASI, A.K., FRIELLE, T. & LEFKOWITZ, R.J. (1990). Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. Biiochemistry, 29, 2335-2342.
33. EMORINE, L.J., MARULLO, S., BRIEND, S.M., PATEY, G., TATE, K., DELAVIER, K.C. & STROSBERG, A.D. (1989), Molecular characterization of the human beta 3-adrenergic receptor. Science, 245, 1118-1121.
34. 3-adrenoceptor mRNA in rat tissues. Br. J. Pharmacol., 117, 210-216.
35. FERGUSON, S., MENARD, L., BARAK, L.S., KOCH, W.J., COLAPIETRO, A.M. & CARON, MG (1995). Role of phosphorylation in agonist-promoted beta2-adrenergic receptor sequestration. Rescue of a sequestration-defective mutant receptor by βARK1. J. Biol. Chem., 270, 24782-24789.
36. 2-adrenergic receptor protein and mRNA levels by glucocorticoids during 3T3-F442A adipocyte differentiation. J. Biol. Chem., 265, 16343-16349.
37. FEVE, B., BAUDE, B., KRIEF, S., STROSBERG, A.D., PAIRAULT, J., EMORINE, L.J. (1992). Inhibition by dexamethasone of beta 3-adrenergic receptor responsiveness in 3T3-F442A adipocytes. Evidence for a transcriptional mechanism. J. Biol. Chem., 267, 15909-15915.
38. FEVE, B., ELHADRI, K., QUIGNARDBOULANGE, A. & PAIRAULT, J. (1994). Transcriptional down-regulation by insulin of the beta(3)-adrenergic receptor expression in 3T3-F442A adipocytes - a mechanism for repressing the cAMP signalling pathway. Proc. Natl. Acad. Sci. USA, 91, 5677-5681.
39. FEVE, B., PIETRIROUXEL, F., ELHADRI, K., DRUMARE, M.F. & STROSBERG, A.D. (1995). Long term phorbol ester treatment down-regulates the beta (3)-adrenergic receptor in 3T3-F442A adipocytes. J. Biol. Chem., 270, 10952-10959.
40. FREEDMAN, N.J., LIGGETT, S.B., DRACHMAN, D.E., PEI, G., CARON, M.G. & LEFKOWITZ, R.J. (1995). Phosphorylation and desensitization of the human beta1-adrenergic receptor. Involvement of G protein-coupled receptor kinase and cAMP-dependent protein kinase. J. Biol. Chem., 270, 17953-17961.
41. FRIELLE, T., COLLINS, S., DANIEL, C.W.O., CARON, M.G., LEFKOWITZ, R.J. & KOBILKA, BK. (1987). Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc. Natl. Acad. Sci. USA, 84, 7920-7924.
42. GAMBARANA, C., ORDWAY, G.A., HAUPTMANN, M., TEJANI-BUTT, S. & FRAZER, A. (1991). Central administration of 1-isoproterenol in vivo induces a preferential regulation of beta 2-adrenoceptors in the central nervous system of the rat. Brain Res., 555, 141-148.
43. GAUTHIER, C., TAVERNIER, G., CHARPENTIER, F., LANGIN, D. & LEMAREC, H. (1996). Functional beta (3)-adrenoceptor in the human heart. J. Clin. Invest., 98, 556-562.
44. GOODMAN, O.B.J., KRUPNICK, J.G., SANTINI, F., GUREVICH, V.V., PENN, R.B., GAGNON, A.W., KEEN, J.H. & BENOVIC, J.L. (1996). Beta-arrestin as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature, 383, 447-450.
45. GRANNEMAN, J.G. & LAHNERS, K.N. (1992). Differential adrenergic regulation of beta1- and beta3-adrenoreceptor messenger ribonucleic acids in adipose tissues. Endocrinology, 130, 109-114.
46. GRANNEMAN, J.G. & LAHNERS, K.N. & CHAUDHRY, A. (1993). Characterization of the human beta 3-adrenergic receptor gene. Mol. Pharmacol., 44, 264-270.
47. GRANNEMAN, J.G. & LAHNERS, K.N. (1995). Regulation of mouse beta(3)-adrenergic receptor gene expression and mRNA splice variants in adipocytes. Am. J. Physiol., Cell Physiol., 37, C1040-C1044.
48. HADCOCK, J.R. & MALBON, C.C. (1993). Agonist regulation of gene expression of adrenergic receptors and G-proteins. J. Neurochem., 60, 1-9.
49. HADCOCK, J.R., PORT, J.D., GELMAN, M.S. & MALBON, C.C. (1992). Cross-talk between tyrosine kinase and G-protein-linked receptors. Phosphorylation of beta 2-adrenergic receptors in response to insulin. J. Biol. Chem., 267, 26017-26022.
50. HAGA, T., HAGA, J. & KAMEYAMA, K. (1994). G-protein-coupled receptor kinases. J. Neurochem., 63, 400-412.
51. HARMS, H.H., ZAAGSMA, J. & VAN DER WAL, B. (1974). β-adrenoceptor studies. III. On the β-adrenoceptors in rat adipose tissue. Eur. J. Pharmacol., 25, 87-91.
52. HARMS, H.H. (1976). Stereochemical aspects of β-adrenoceptor antagonist-receptor interaction in adipocytes. Differentiation of β-adrenoceptors in human and rat adipocytes. Life Sci., 19, 1447-1452.
53. HARMS, H.H., ZAAGSMA, J. & DE VENTE, J. (1977). Differentiation of beta-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat, using streoisomers of propranolol, nifenalol and practolol. Life Sci., 21, 123-128.
54. HARTZELL, H.C., MERY, P.F., FISCHMEISTER, R. & SZABO, G. (1991). Sympathetic regulation of cardiac calcium current is due exclusively to cAMP-dependent phosphorylation. Nature, 351, 573-576.
55. HAUSDORFF, W.P., BOUVIER, M., O'DOWD, B.F., IRONS, G.P., CARON, M.G. & LEFKOWITZ, R.J. (1989). Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J. Biol. Chem., 264, 12657-12665.
56. HAUSDORFF, W.P., HNATOWICH, M., O'DOWD, B.F., CARON, M.G. & LEFKOWITZ, R.J. (1990). A mutation of the beta 2-adrenergic receptor impairs agonist activation of adenylyl cyclase without affecting high affinity agonist binding. Distinct molecular determinants of the receptor are involved in physical coupling to and functional activation of Gs. J. Biol. Chem., 265, 1388-1393.
57. JELSEMA, C.L. & AXELROD, J. (1987). Stimulation of phospholipase A2 activity in bovine rod outer segments by the beta gamma subunits of transducin and its inhibition by the alpha subunit. Proc. Natl. Acad. Sci. USA, 84, 3623-3627.
58. + channel inhibitor. J. Pharmacol. Exp. Ther., 255, 697-706.
59. JONES, T.R., CHARETTE, L., GARCIA, M.L. & KACZOROWSKI, G.J. (1993). Interaction of iberiotoxin with beta-adrenoceptor agonists and sodium nitroprusside on guinea pig trachea. J. Appl. Physiol., 74, 1879-1884.
60. KAUMANN, A.J. (1989) Is there a third heart beta-adrenoceptor? Trends Pharmacol. Sci., 10, 316-320.
61. KAUMANN, A.J. (1997) Four β-adrenoceptor subtypes in the mammalian heart. Trends Pharmacol. Sci., 18, 70-76.
62. KIELY, J., HADCOCK, J.R., BAHOUTH, S.W. & MALBON, C.C (1994). Glucocorticoids down-regulate beta 1-adrenergic-receptor expression by suppressing transcription of the receptor gene. Biochem. J., 302, 397-403.
63. KOBILKA, B.K., DIXON, R.A., FRIELLE, T., DOHLMAN, H.G., BOLANOWSKI, M.A., SIGAL, I.S., YANG-FENG, T.L., FRANCKE, U., CARON, M.G. & LEFKOWITZ, R.J. (1987). cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for plateletderived growth factor. Proc. Natl. Acad. USA, 84, 46-50.
64. KOBILKA, B.K., KOBILKA, T.S., DANIEL, K., REGAN, J.W., CARON, M.G. & LEFKOWITZ, R. J. (1988). Chimeric alpha 2-, beta 2-adrenergic receptors, delineation of domains involved in effector coupling and ligand binding specificity. Science, 240, 1310-1316.
65. KOCH, W.J., ROCKMAN, H.A., SAMAMA, P., HAMILTON, R.A., BOND, R.A., MILANO, C.A & LEFKOWTITZ, R.J. (1995). Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a β-ark inhibitor. Science, 268, 1350-1353.
66. KOMPA, A.R., MOLENAAR, P. & SUMMERS, R.J. (1992). Regulation of guinea-pig cardiac β-adrenoceptor subtypes after (-)-adrenaline and (-)-noradrenaline treatment. Mol. Neuropharmacol., 1, 203-210.
67. KRIEF, S., FEVE., B., BAUDE, B., ZILBERFARB, V., STROSBERG, A.D., PAIRAiH T, J. & EMORINE, L.J. (1994). Transcriptional modulation by n-butyric acid of beta 1, beta 2-, and beta 3-adrenergic receptor balance in 3T3-F442A adipocytes. J. Biol. Chem., 269, 6664-6670.
68. KUME, H., GRAZIANO, M. P. & KOTLIKOFF, M.I. (1992). Stimulatory and inhibitory regulation of calcium-activated potassium channels by guanine nucleotide-binding proteins. Proc. Natl. Acad. Sci. USA, 89, 11051-11055.
69. KUME, H., HALL, I.P., WASHABAU, R.J., TAKAGI, K. & KOTLIKOFF, M.I. (1994). Beta-adrenergic agonists regulate KCa channels in airway smooth muscle by cAMP-dependent and -independent mechanisms. J. Clin. Invest., 93, 371-379.
70. LIGGETT, S.B., CARON, M.G., LEFKOWITZ, R.J. & HNATOWICH, M. (1991). Coupling of a mutated form of the human beta 2-adrenergic receptor to Gi and Gs. Requirement for multiple cytoplasmic domains in the coupling process. J. Biol. Chem., 266, 4816-4821.
71. LIGGETT, S. B., FREEDMAN, N.J., SCHWINN, D.A. & LEFKOWITZ, R.J. (1993). Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. Proc. Natl Acad. Sci. USA, 90, 3665-3669.
72. LIU, Y.L. & STOCK, M.J. (1995). Acute effects of the beta3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation. Br. J. Pharmacol., 114, 888-894.
73. + channel in heart. Nature, 325, 321-326.
74. LOHSE, M.J., KRASEL, C., WINSTEL, R. & MAYOR, F.J. (1996). G-protein-coupled receptor kinases. Kidney Int., 49, 1047-1052.
75. MANARA, L., CROCI, T. & LANDI, M. (1995) Beta3-adrenoceptors and intestinal motility. Fund. Clin. Pharmacol., 9, 332-342.
76. MANARA, L. & BIANCHETTI, A. (1990). Further heterogeneity of the beta-adrenoceptor. The phenylethanolaminotetralines: new selective agonists for atypical beta-adrenoceptors. Trends Pharmacol. Sci., 11, 229-230.
77. 2-adrenergic receptors in rat cerebral cortex are independently regulated. Science, 204, 866-868.
78. MIURA, M., BELVISI, M.G., STRETTON, C.D., YACOUB, M.H. & BARNES, P.J. (1992). Role of potassium channels in bronchodilator responses in human airways. Am. Rev. Respir. Dis., 146, 132-136.
79. 2-adrenoceptors in guinea-pig atrio ventricular conducting system after chronic (-)isoprenaline infusion. J. Pharmacol. Exp. Ther., 255, 393-400.
80. MUMBY, S.M., KAHN, R.A., MANNING, D.R. & GILMAN, A.G. (1986). Antisera of designed specificity for subunits of guanine nucleotide-binding regulatory proteins. Proc. Natl. Acad. Sci. USA, 83, 263-269.
81. NAKADA, M.T., STADEL, J.M. & CROOKE, S.T. (1990). Subtype-selective regulation of beta-adrenergic receptor-adenylyl cyclase coupling by phorbol esters in 3T3-L1 fibroblasts. J. Pharmacol. Exp. Ther., 253, 221-229.
82. NANOFF, C., FREISSMUTH, M., TUISL, E. & SCHUTZ, W. (1989). A different desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline. J. Cardiovasc. Pharmacol., 13, 198-203.
83. NANTEL, F., BONIN, H., FMORINE, L.J., ZILBERFARB, V., STROSBERG, A.D., BOUVIER, M. & MARULLO, S. (1993). The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol. Pharmacol., 43, 548-555.
84. NORTHUP, J.K., SMIGEL, M.D., STERNWEIS, P.C. & GILMAN, A.G. (1983). The subunits of the stimulatory regulatory component of adenylate cyclase. Resolution of the activated 45,000 dalton (alpha) subunit. J. Biol. Chem., 258, 11369-11376.
85. 341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J. Biol. Chem., 264, 7564-7569.
86. OKAMOTO, T., MURAYAMA, Y., HAYASHI, Y., INAGAKI, M., OGATA, E. & NISHIMOTO, I. (1991). Identification of a Gs activator region of the beta 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell, 67, 723-730.
87. ONO, K., KIYOSUE, T. & ARITA, M. (1989). Isoproterenol, DBcAMP, and forskolin inhibit cardiac sodium current. Am. J. Physiol., 256, C1131-1137.
88. ORDWAY, G.A., GAMBARANA, C. & FRAZER, A. (1988). Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered 1-isoproterenol. J. Pharmacol. Exp. Ther., 247, 379-389.
89. PERKINS, J.P., HAUSDORFF, W.P. & LEFKOWITZ, R.J. (1991). In The β-adrenergic receptor. pp125-180. Ed. J.P. Perkins, Humana Press, Clifton, N.J.
90. PIETRI-ROUXEL, F. & STROSBERG, A.D. (1995). Pharmacological characteristics and species-related variations of beta 3-adrenergic receptors. Fundam. Clin. Pharmacol., 9, 211-218.
91. PIPPIG, S., ANDEXINGER, S., DANIEL, K., PUZICHA, M., CARON, M.G., LEFKOWITZ, R.J. & LOHSE, M.J. (1993). Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors. J. Biol. Chem., 268, 3201-3208.
92. PORT, J.D., HUANG, L.G. & MALBON, C. C. (1992). Beta-adrenergic agonists that down-regulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs. J. Biol. Chem., 267, 24103-24108.
93. 125]-cyanopindolol binding sites in rat soleus muscle. Br. J. Pharmacol., 109, 344-352.
94. ROBISHAW, J.D., SMIGEL, M.D. & GILMAN, A.G. (1986). Molecular basis for two forms of the G protein that stimulates adenylate cyclase. J. Biol. Chem., 261, 9587-9590.
95. RUBIO, A., RASSMAJA, A. & SILVA, J.E. (1995). Thyroid hormone and norepinephrine signalling in brown adipose tissue 2. Differential effects of thyroid hormone on beta (3)-adrenergic receptors in brown and white adipose tissue. Endocrinology, 136, 3277-3284.
96. SAFFITZ, J.E. & LIGGETT, S.B. (1992). Subcellular distribution of beta 2-adrenergic receptors delineated with quantitative autoradiography of radioligand binding sites. Circ. Res., 70, 1320-1315.
97. SCHUBERT, B., VANDONGEN, A.M., KIRSCH, G.E. & BROWN, A.M. (1989). Beta-adrenergic inhibition of cardiac sodium channels by dual G-protein pathways. Science, 245, 516-519.
98. SILENCE, M.N., MOORE, N.G., PEGG, G.G. & LINDSAY, D.B. (1993). Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes. Br. J. Pharmacol., 109, 1157-1163.
99. STRADER, C.D., SIGAL, I.S. & DIXON, R.A. (1989). Structural basis of beta-adrenergic receptor function. FASEB J., 3, 1825-1832.
100. STROSBERG, A.D. (1995a). Structural and functional diversity of beta-adrenergic receptors. Ann. NY Acad. Sci., 757, 253-260.
101. 3-adrenoceptor subtypes. In: G-protein Coupled Transmembrance Signaling Mechanisms. pp 35-56 Eds. R.R.J. Ruffolo & M.A. Hollinger. CRC Press, Boca Raton.
102. 3-adrenoceptor. Anu. Rev. Pharmacol. Toxicol., 37, 421-450.
103. STROSBERG, A.D. & PIETRI-ROUXEL, F. (1996). Function and regulation of the three β-adrenoceptor. Trends Pharmacol. Sci., 17, 373-381.
104. SUMMERS, R.J. (1992). Localization and regulation of β-adrenoceptor subtypes. In: Receptor Autoradiography: Principles and Practice, pp. Ed. Oxford University Press, Oxford.
105. SUMMERS, R.J. & MCMARTIN, L.R. (1993). Adrenoceptors and their second messenger systems. J. Neurochem., 209, 257-262.
106. TOTA, M.R. & STRADER, C.D. (1990). Characterization of the binding domain of the beta-adrenergic receptor with the fluorescent antagonist carazolol. Evidence for a buried ligand binding site. J. Biol. Chem., 265, 16891-16897.
107. TOTA, M.R., CANDELORE, M.R., DIXON, R.A. & STRADER, C.D. (1991). Biophysical and genetic analysis of the ligand binding site of the β-adrenoceptor. Trends Pharmacol. Sci., 12, 4-6.
108. VON ZASTROW, M. & KOBILKA, B.K (1992). Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J. Biol. Chem., 267, 3530-3538.
109. WALDO, G.L., NORTHUP, J.K., PERKINS, J.P. & HARDEN, T.K. (1983). Characterization of an altered membrane form of the beta-adrenergic receptor produced during agonist-induced desensitization. J. Biol. Chem., 258, 13900-13908.
110. XIAO, R.P., JI, X. & LAKATTA, E.G. (1995). Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol. Pharmacol., 47, 322-329.
111. YATANI, A., CODINA, J., IMOTO, Y., REEVES, J.P., BIRNBAUMER, L. & BROWN, A.M. (1987). A G protein directly regulates mammalian cardiac calcium channels. Science, 238, 1288-1292.
112. YATANI, A. & BROWN, A.M. (1989). Rapid beta-adrenergic modulation of cardiac calcium channel currents by a fast G protein pathway. Science, 245, 71-74.
113. YU, S.S., LEFKOWITZ, R.J. & HAUSDORFF, W.P. (1993). Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J. Biol. Chem., 268, 337-341.